EDGAR Filing Documents for 0001558370-24-004246

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-24-004246

Filing Date

2024-03-28

Accepted

2024-03-28 16:06:06

Documents

Period of Report

2023-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	nrbo-20231231x10k.htm iXBRL	10-K	2439540
2	EX-3.6	nrbo-20231231xex3d6.htm	EX-3.6	176327
3	EX-21.1	nrbo-20231231xex21d1.htm	EX-21.1	5609
4	EX-23.1	nrbo-20231231xex23d1.htm	EX-23.1	3290
5	EX-31.1	nrbo-20231231xex31d1.htm	EX-31.1	38380
6	EX-31.2	nrbo-20231231xex31d2.htm	EX-31.2	37900
7	EX-32.1	nrbo-20231231xex32d1.htm	EX-32.1	8529
8	EX-32.2	nrbo-20231231xex32d2.htm	EX-32.2	8534
9	EX-97.1	nrbo-20231231xex97d1.htm	EX-97.1	99560
10	GRAPHIC	nrbo-20231231x10k001.jpg	GRAPHIC	10438
11	GRAPHIC	nrbo-20231231x10k002.jpg	GRAPHIC	20233
12	GRAPHIC	nrbo-20231231x10k003.jpg	GRAPHIC	64765
13	GRAPHIC	nrbo-20231231x10k004.jpg	GRAPHIC	18390
14	GRAPHIC	nrbo-20231231x10k005.jpg	GRAPHIC	33134
15	GRAPHIC	nrbo-20231231x10k006.jpg	GRAPHIC	40328
16	GRAPHIC	nrbo-20231231x10k007.jpg	GRAPHIC	58609
17	GRAPHIC	nrbo-20231231x10k008.jpg	GRAPHIC	78860
18	GRAPHIC	nrbo-20231231xex97d1001.jpg	GRAPHIC	7220
19	GRAPHIC	nrbo-20231231xex97d1004.jpg	GRAPHIC	8143
20	GRAPHIC	nrbo-20231231xex97d1005.jpg	GRAPHIC	715
	Complete submission text file	0001558370-24-004246.txt		10376097

Data Files

Seq	Description	Document	Type	Size
21	EX-101.SCH	nrbo-20231231.xsd	EX-101.SCH	53731
22	EX-101.CAL	nrbo-20231231_cal.xml	EX-101.CAL	48118
23	EX-101.DEF	nrbo-20231231_def.xml	EX-101.DEF	237457
24	EX-101.LAB	nrbo-20231231_lab.xml	EX-101.LAB	537638
25	EX-101.PRE	nrbo-20231231_pre.xml	EX-101.PRE	420622
96	EXTRACTED XBRL INSTANCE DOCUMENT	nrbo-20231231x10k_htm.xml	XML	1461735

Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138

Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600

NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)